Abstracts - faqs.org

Abstracts

Pharmaceuticals and cosmetics industries

Search abstracts:
Abstracts » Pharmaceuticals and cosmetics industries

The influence of endocardial endothelium on myocardial contraction

Article Abstract:

The mechanisms of action, physiology and pathophysiological relevance of endocardin and endothelium-derived relaxing factor were studied. Endocardin and endothelium-derived relaxing factor (EDRF) are both released from endocardial endothelium but have opposite effects, the former prolongs while the latter abbreviates myocardial contraction. In vitro and in vivo experiments demonstrate that the endocardial endothelium exerts both prolonging and abbreviating effects on myocardial contraction. Furthermore, the endocardial endothelium is shown to alter inotropic responses to different agonists.

Author: Smith, Jerry A., Shah, Ajay M., Fort, Steve, Lewis, Malcolm J.
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1992
Endothelium-derived relaxing factors

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Myocardial preconditioning as the heart's self-protecting response against the consequences of ischaemia

Article Abstract:

An initial ischaemic stimulus preconditions the myocardium and increases the heart's tolerance for further damage. Myocardial preconditioning reduces infarct size, decreases arrhythmia and degree of myocardial stunning through various mechanisms. The initial preconditioning occlusion must be between one and five minutes in duration and the period of reperfusion must exceed one minute. Proposed mechanisms of preconditioning include the release of adenosine and endogenous cardioprotective substances such as prostacyclin, nitric oxide and bradykinins.

Author: Wainwright, Cherry L.
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1992
Research, Heart attack, Perfusion (Physiology)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Low-frequency components of cardiovascular variabilities as markers of sympathetic modulation

Article Abstract:

A study was conducted to characterize the action of the low-frequency components of cardiovascular variabilities on the dynamics of the sympathetic and vagal balance using autoregressive spectral analyses. Results showed that the two major rhythms involved in heart rate variability reflects the balance between sympatho-vagal activities. They also showed a correlation between the activity in vasomotor tone and the low-frequency component of systolic arterial pressure.

Author: Pagani, Massimo, Rimoldi, Ornella, Malliani, Alberto
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1992
Reports, Cardiovascular research

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Physiological aspects, Heart, Heart contraction
Similar abstracts:
  • Abstracts: Frequency use of botanicals. Fragrance stability in three cosmetic applications
  • Abstracts: Endothelin: a knockout in London. California dreamin' 'bout endothelin: emerging new therapeutics. The Institute of Pharmacology of Sherbrooke: a first in Canada
  • Abstracts: Physiological basis of multicompartmental models of drug distribution. The genetic basis of malignant hyperthermia
  • Abstracts: Anthranoid laxatives and colorectal cancer. Nucleoside diphosphate kinases as potential new targets for control of development and cancer
  • Abstracts: Amyloidogenesis in Alzheimer's disease: some possible therapeutic opportunities. part 2 Neuropeptides and nociception: recent advances and therapeutic implications
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.